Radionuclide production for therapeutic radiopharmaceuticals

Radionuclide production for therapeutic radiopharmaceuticals.

A fundamental task within the framework of a project searching for new radiopharmaceuticals for systemic therapy was the evaluation of the capabilities of the Portuguese Research Reactor (RPI) for the production of several important radionuclides. The feasibility of producing 64Cu, 77As, 153Sm, 165Dy, 166Ho, 170Tm, 177Lu, 186Re, 199Au and 111Ag in useful quantities was evaluated for the present...

188Re(V) Nitrido Radiopharmaceuticals for Radionuclide Therapy

The favorable nuclear properties of rhenium-188 for therapeutic application are described, together with new methods for the preparation of high yield and stable 188Re radiopharmaceuticals characterized by the presence of the nitride rhenium core in their final chemical structure. 188Re is readily available from an 188W/188Re generator system and a parallelism between the general synthetic proc...

Therapeutic and diagnostic radiopharmaceuticals#

Medical application of ionizing radiation and radioactive isotopes were considered almost immediately after their discovery. The intense research interest in radioactivity, materials structure, subatomic particles and in the establishment of physical principles resulted in milestone inventions such as the radiotracer principle, particle accelerators, nuclear reactors and detectors sensitive eno...

Radiopharmaceuticals: Production and Availability

1. The use of specific radiotracers called radiopharmaceuticals for imaging organ function and disease states is a unique capability of nuclear medicine. Unlike other imaging modalities such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI) and Ultrasonography (US), nuclear medicine procedures are capable of mapping physiological function and metabolic activity and thereby giving mo...

IAEA - TECDOC - 1228 Therapeutic applications of radiopharmaceuticals